title: Cutaneous lymphoid perivascular reaction with atypical CD30+ T cells in a patient with multiple myeloma treated with bortezomib.
authors.forename: L
authors.initials: L
authors.lastname: Dehesa
authors.forename: J
authors.initials: J
authors.lastname: Bastida
authors.forename: M
authors.initials: M
authors.lastname: Limeres-González
authors.forename: C
authors.initials: C
authors.lastname: Campos-Adsuar
authors.forename: J
authors.initials: J
authors.lastname: Gómez-Duaso
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D017730:Ki-1 Antigen / Q000276:immunology*; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000276:immunology; D011719:Pyrazines / Q000009:adverse effects*; D016176:T-Lymphocyte Subsets / Q000276:immunology*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D017730:Ki-1 Antigen; D011719:Pyrazines; D000069286:Bortezomib